by Lean Biologix | Aug 22, 2022 | Supply Chain Testing
A global biotechnology company working toward regulatory approval of a gene therapy treatment was required to perform shipping validation to support review and approval in the US market. As the primary indication was targeted for fatal neuromuscular genetic disease...
by Lean Biologix | Aug 22, 2022 | Supply Chain Testing
A leading fortune 500 company headquartered in Cambridge, MA was planning to launch a number of biological products into new markets for the first time. Product specific shipping qualification was performed and qualified shipping containers were in use for domestic...
by Lean Biologix | Aug 5, 2022 | Supply Chain Testing
A leading cell and gene therapy CDMO located in Cambridge, MA desired to qualify and implement platform shipping systems that could maintain their product requirements and regulatory compliance. Challenges Aggressive timeline to complete qualification and...
